Which companies overlap with Intergroupe Francophone de Cancerologie Thoracique's portfolio?

Top competitors by shared drug class: Jiangsu HengRui Medicine Co., Ltd., Akeso, Chinese Academy of Medical Sciences, Henan Cancer Hospital, Jiangsu Cancer Institute & Hospital.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/intergroupe-francophone-de-cancerologie-thoracique.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Intergroupe Francophone de Cancerologie Thoracique — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intergroupe Francophone de Cancerologie Thoracique pipeline: 1 marketed, 0 filed, 3 Phase 3, 3 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 3 Phase 3 3 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Customized Treatment	Customized Treatment	marketed			Oncology
Chemotherapy with platine	Chemotherapy with platine	phase 3	Platinum-based chemotherapy agent	DNA	Oncology
Gemcitabine alone	Gemcitabine alone	phase 3	Nucleoside analog antimetabolite	Ribonucleotide reductase; DNA polymerase	Oncology
Paclitaxel + Carboplatine	Paclitaxel + Carboplatine	phase 3	Chemotherapy combination (taxane + platinum agent)	β-tubulin (paclitaxel); DNA (carboplatin)	Oncology

Therapeutic area mix

Oncology · 5

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Jiangsu HengRui Medicine Co., Ltd. · 3 shared drug classes
Akeso · 2 shared drug classes
Chinese Academy of Medical Sciences · 2 shared drug classes
Henan Cancer Hospital · 2 shared drug classes
Jiangsu Cancer Institute & Hospital · 2 shared drug classes
Amgen · 2 shared drug classes
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · 2 shared drug classes
Memorial Sloan Kettering Cancer Center · 2 shared drug classes

Subscribe to ongoing alerts

Every new pipeline event for Intergroupe Francophone de Cancerologie Thoracique:

Cite this brief

Drug Landscape (2026). Intergroupe Francophone de Cancerologie Thoracique — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/intergroupe-francophone-de-cancerologie-thoracique. Accessed 2026-05-17.